Kurt Fernstrom

Array ( [id] => 14697677 [patent_doc_number] => 10376561 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-08-13 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 15/156284 [patent_app_country] => US [patent_app_date] => 2016-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 9701 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16815261 [patent_doc_number] => 11000057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-11 [patent_title] => Fasting mimicking and enhancing diet for treating hypertension and lipid disorders [patent_app_type] => utility [patent_app_number] => 15/148251 [patent_app_country] => US [patent_app_date] => 2016-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 32 [patent_no_of_words] => 8125 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11107607 [patent_doc_number] => 20160304570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7' [patent_app_type] => utility [patent_app_number] => 15/134305 [patent_app_country] => US [patent_app_date] => 2016-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 127 [patent_figures_cnt] => 127 [patent_no_of_words] => 143798 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15068489 [patent_doc_number] => 10463710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders [patent_app_type] => utility [patent_app_number] => 15/569142 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11955 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15068487 [patent_doc_number] => 10463709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Short synthetic peptide for treating diseases and/or conditions related to angiogenesis [patent_app_type] => utility [patent_app_number] => 15/569122 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14444 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14945777 [patent_doc_number] => 10434134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-08 [patent_title] => Peptide treatment for inflammation and fibrosis [patent_app_type] => utility [patent_app_number] => 15/570910 [patent_app_country] => US [patent_app_date] => 2016-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 58 [patent_no_of_words] => 30712 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13982509 [patent_doc_number] => 20190060412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => PHARMACEUTICAL COMPOSITION AND MANUFACTURING METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 16/079996 [patent_app_country] => US [patent_app_date] => 2016-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11567298 [patent_doc_number] => 20170105943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'COMPOSITION FOR PROMOTION OF WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 15/052916 [patent_app_country] => US [patent_app_date] => 2016-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2094 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15052916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16259976 [patent_doc_number] => 10751385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Prevention and/or treatment of hearing loss or impairment [patent_app_type] => utility [patent_app_number] => 15/551096 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 23 [patent_no_of_words] => 38605 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11046233 [patent_doc_number] => 20160243190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'DOSES AND METHODS FOR ADMINISTERING TELAVANCIN' [patent_app_type] => utility [patent_app_number] => 15/046664 [patent_app_country] => US [patent_app_date] => 2016-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18921 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15046664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11348902 [patent_doc_number] => 20160367642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'MINIMIZING INTESTINAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 15/044356 [patent_app_country] => US [patent_app_date] => 2016-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2810 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15044356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10812157 [patent_doc_number] => 20160158317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'Antimicrobial Peptide Variants and Polynucleotides Encoding Same' [patent_app_type] => utility [patent_app_number] => 15/043547 [patent_app_country] => US [patent_app_date] => 2016-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30659 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11120561 [patent_doc_number] => 20160317535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHOD OF PREVENTING OR TREATING SKIN NECROPTOSIS DISEASE COMPRISING RIP3-MLKL PATHWAY BLOCKER' [patent_app_type] => utility [patent_app_number] => 15/017470 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6011 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12099202 [patent_doc_number] => 09856289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Peptides capable of reactivating p53 mutants' [patent_app_type] => utility [patent_app_number] => 15/015208 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 39 [patent_no_of_words] => 36572 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11009789 [patent_doc_number] => 20160206741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'HYDROGELS FOR DELIVERY OF THERAPEUTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/994704 [patent_app_country] => US [patent_app_date] => 2016-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 26562 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14994704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13297271 [patent_doc_number] => 20180200172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => REAGENTS AND METHODS FOR WHITENING TEETH [patent_app_type] => utility [patent_app_number] => 15/542902 [patent_app_country] => US [patent_app_date] => 2016-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14029563 [patent_doc_number] => 10226513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration [patent_app_type] => utility [patent_app_number] => 14/990248 [patent_app_country] => US [patent_app_date] => 2016-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2622 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10767839 [patent_doc_number] => 20160113995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'LIPID NANOPARTICLE OF POLYMYXIN' [patent_app_type] => utility [patent_app_number] => 14/985532 [patent_app_country] => US [patent_app_date] => 2015-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7324 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10760700 [patent_doc_number] => 20160106853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'CURCUMIN CONJUGATES FOR TREATING AND PREVENTING CANCERS' [patent_app_type] => utility [patent_app_number] => 14/977426 [patent_app_country] => US [patent_app_date] => 2015-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9971 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16244764 [patent_doc_number] => 10744088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Method for preparing ophthalmic preparation containing thymosin beta-4 [patent_app_type] => utility [patent_app_number] => 15/752118 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3402 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752118 [rel_patent_id] =>[rel_patent_doc_number] =>)